Diacylglycerol-induced stimulation of neurotransmitter release from rat brain striatal synaptosomes.
These studies were undertaken to test the hypothesis that alterations in phosphatidylinositol metabolism can modulate neurotransmitter release in the central nervous system. The effects of 1,2-diacylglycerols (DAGs) on dopamine release in the rat central nervous system were determined by measuring dopamine release from rat striatal synaptosomes in response to two DAGs (sn-1,2-dioctanoylglycerol and 1-oleoyl-2-acetylglycerol) that can activate protein kinase C and one DAG (deoxydioctanoylglycerol) that does not activate this kinase. Dioctanoylglycerol and 1-oleoyl-2-acetylglycerol, at a concentration of 50 micrograms/ml, stimulated the release of labeled dopamine from striatal synaptosomes by 35-50 and 17%, respectively. Dioctanoylglycerol-induced release was also demonstrated for endogenous dopamine. In contrast, deoxydioctanoylglycerol (50 micrograms/ml) did not stimulate dopamine release. Dioctanoylglycerol-induced dopamine release was independent of external calcium concentration, indicating a utilization of internal calcium stores. Dioctanoylglycerol (50 micrograms/ml) also produced a 38% increase in labeled serotonin release from striatal synaptosomes. The addition of dioctanoylglycerol to the striatal supernatant fraction increased protein kinase C activity. These results are consistent with the concept that an increase in phosphatidylinositol metabolism can stimulate neurotransmitter release in the central nervous system via an increase in DAG concentration. The data suggest an involvement of protein kinase C in the DAG-induced release, but other sites for DAG action are also possible.
Davis
M E
ME
Division of Biology and Medicine, Brown University, Providence, RI 02912.
Patrick
R L
RL
D000818:Animals; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism*; D004075:Diglycerides / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D005989:Glycerides / Q000494:pharmacology*; D011493:Protein Kinase C / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D012995:Solubility; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism*
D004075:Diglycerides; D005989:Glycerides; D012701:Serotonin; C038237:1-oleoyl-2-acetylglycerol; D011493:Protein Kinase C; D002118:Calcium; D004298:Dopamine